Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Newer TB jabs losing potency

  • Comment
Newer TB vaccines are losing their effectiveness and older versions may have to be brought back, say French researchers.

Newer TB vaccines are losing their effectiveness and older versions may have to be brought back, say French researchers.

Recent forms of the Bacillus Calmette Guerin (BCG)jab work very well in children, but the protection they afford adults varies from 0 to 80%, depending on country, say the researchers.

They said genetic changes in the newer BCG versions have resulted in more variability and have weakened their potency.

Research published last year showed that an older Japanese strain prompted a greater degree of protection in babies than a newer Danish strain.

Newer versions account for two thirds of the 335 million doses injected worldwide, and were developed because they produced fewer side effects.

PNAS online (2007) www.pnas.org

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs